Search - tctmd.com

Presenter: Joseph Kim, Helen Vlachos, Suresh R. Mulukutla, Catalin Toma, Joon S. Lee, David O. Williams, Sheryl F. Kelsey, Kevin E. Kip, Oscar C. Marroquin

January 03, 2012

News Daily News

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

L.A. McKeown

October 21, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Daily News

Frailty Status Improves Prediction of Long-term Outcomes in PCI Patients

Caitlin E. Cox

September 09, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Daily News

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

Caitlin E. Cox

August 19, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

August 18, 2011

News Daily News

Natriuretic Peptide Protects Kidney Function in CABG Patients with CKD

August 15, 2011

News Daily News

High Homocysteine Levels Linked with Contrast Nephropathy

Jason Kahn

July 28, 2011

News Daily News

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

June 22, 2011

News Conference News

Induced Diuresis with Automated Hydration Therapy Reduces CIN

April 05, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

April 04, 2011

News Daily News

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

L.A. McKeown

March 29, 2011

News Daily News

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Caitlin E. Cox

March 18, 2011

Advertisement

SCAI Publishes Cath Lab Best Practices

Hospital Readmission After PCI ‘High’

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Registry Study: One-Year Outcomes Similar for TAVR, Surgery

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

DES Shows Slight Edge Over BMS in Patients with Kidney Disease

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Frailty Status Improves Prediction of Long-term Outcomes in PCI Patients

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

REMEDIAL II Published: New Therapy Prevents Contrast-Induced Kidney Damage

REMEDIAL II Trial of PLC's RenalGuard® Article Published in Circulation

Natriuretic Peptide Protects Kidney Function in CABG Patients with CKD

High Homocysteine Levels Linked with Contrast Nephropathy

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

Induced Diuresis with Automated Hydration Therapy Reduces CIN

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content